Additionally, we found that exogenous COL1 treatment of T24 bladder cancer cells significantly enhanced the mRNA expression of CD167a, but not other candidate collagen receptors, nor to the extent of CD167a induction (Supplementary Fig. 1). This evidence concerns the gene ITGA2 and urinary bladder cancer.